First-in-class Peroxiredoxin 3 (PRX3) Inhibitor RSO-021 Triggers Mesenchymal-to-epithelial Transition in Mesothelioma
Cancer Research(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined